8-K Announcements
6Material company update
Jun 4, 2026·SEC
Material company update
May 20, 2026·SEC
Material company update
May 6, 2026·SEC
Aimei Health Technology Co., Ltd(AFJK)Earnings, Financials & Key Ratios
AFJK•NASDAQ•Banking & Credit
200.1× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustrySPACs & Shell CompaniesSub-IndustryHealthcare and life sciences SPACs
AboutAimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.Show more
- Net Interest Income$2M-47.6%
- Total Revenue$0
- Net Income$1M-58.5%
- Return on Equity2.64%-26.6%
- Net Interest Margin15.66%+219.6%
- ROA2.47%-30.3%
- Equity / Assets66.44%-32.2%
- Book Value per Share1.99-75.2%
AFJK Key Insights
Aimei Health Technology Co., Ltd (AFJK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong NIM of 15.7%
- ✓Well capitalized: 66.4% equity/assets
- ✓Share count reduced 55.2% through buybacks
✗Weaknesses
- ✗Weak 3Y average ROE of 2.2%
- ✗Weak Piotroski F-Score: 2/9
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 17.1x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AFJK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AFJK Price & Volume
Aimei Health Technology Co., Ltd (AFJK) stock price & volume — 10-year historical chart
Loading chart...
AFJK Growth Metrics
Aimei Health Technology Co., Ltd (AFJK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-53.54%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-25.68%
Return on Capital
10 Years-1.19%
5 Years-1.19%
3 Years-1.19%
Last Year-2.05%
AFJK Recent Earnings
Aimei Health Technology Co., Ltd (AFJK) EPS & revenue vs analyst estimates — last 4 quarters
Q3 2026Latest
Jun 16, 2026Metric
Actual
Est
EPS
$0.01
—
Rev
—
—
Q2 2026
May 4, 2026Metric
Actual
Est
EPS
$0.02
—
Rev
—
—
Q2 2026
Apr 3, 2026Metric
Actual
Est
EPS
$0.05
—
Rev
—
—
Q4 2025
Nov 18, 2025Metric
Actual
Est
EPS
$0.06
—
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 16, 2026 | $0.01 | — |
| Q2 2026 | May 4, 2026 | $0.02 | — |
| Q2 2026 | Apr 3, 2026 | $0.05 | — |
| Q4 2025 | Nov 18, 2025 | $0.06 | — |
Based on last 11 quarters of dataView full earnings history →
AFJK Peer Comparison
Aimei Health Technology Co., Ltd (AFJK) competitors in Healthcare and life sciences SPACs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CANG | 120.56M | 0.31 | -0.19 | 498.08% | -91.96% | -60.5% | 1.41 | |
 BTBT | 706.64M | 2.17 | -7 | -30.65% | -146.01% | -0.11% | 0.16 | |
 CLOV | 2.59B | 5.00 | -29.41 | 40.34% | -2.58% | -17.08% | ||
 ACMR | 7.28B | 109.87 | 80.20 | 15.24% | 9.48% | 5.13% | 0.16 | |
 GDRX | 922.03M | 2.66 | 31.18 | 0.57% | 3.74% | 4.75% | 0.10 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 140.85M | 8.43 | -1.41 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare AFJK vs Peers
Aimei Health Technology Co., Ltd (AFJK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AFJK Income Statement
Aimei Health Technology Co., Ltd (AFJK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Net Interest Income | 199.85K | 3.62M | 1.9M | 1.3M |
NII Growth % | - | 1709.88% | -47.59% | -256.87% |
Net Interest Margin % | 0.28% | 4.9% | 15.66% | 10.55% |
Interest Income | 199.85K | 3.62M | 1.9M | 1.3M |
Interest Expense | 0 | 0 | 0 | 0 |
Loan Loss Provision | 0 | 0 | 0 | 0 |
Non-Interest Income | -199.85K | -3.62M | -1.9M | -1.3M |
Non-Interest Income % | - | - | - | - |
Total Revenue | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% |
Revenue Growth % | - | - | - | 0% |
Non-Interest Expense | 28.46K | 1.06M | 835.76K | 484.33K |
Efficiency Ratio | - | - | - | - |
Operating Income | -28.46K▲ 0% | -1.06M▼ 3642.2% | -835.76K▲ 21.5% | -484.33K▲ 0% |
Operating Margin % | - | - | - | - |
Operating Income Growth % | - | -3642.23% | 21.52% | - |
Pretax Income | 171.39K▲ 0% | 2.55M▲ 1389.0% | 1.06M▼ 58.5% | 920.55K▲ 0% |
Pretax Margin % | - | - | - | - |
Income Tax | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% |
Net Income | 171.39K▲ 0% | 2.55M▲ 1389.0% | 1.06M▼ 58.5% | 920.55K▲ 0% |
Net Margin % | - | - | - | - |
Net Income Growth % | - | 1389.01% | -58.47% | -53.54% |
Net Income (Continuing) | 171.39K | 2.55M | 1.06M | 920.55K |
EPS (Diluted) | 0.02▲ 0% | 0.28▲ 1373.7% | 0.17▼ 39.3% | 0.88▲ 0% |
EPS Growth % | - | 1373.68% | -39.29% | -25.68% |
EPS (Basic) | 0.02 | 0.28 | 0.17 | - |
Diluted Shares Outstanding | 9.03M | 9.03M | 4.05M | 1.04M |
AFJK Balance Sheet
Aimei Health Technology Co., Ltd (AFJK) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Cash & Short Term Investments | 580.72K | 28.21K | 2.93K | 26.56K |
Cash & Due from Banks | 580.72K | 28.21K | 2.93K | 18.52K |
Short Term Investments | 0 | 0 | 0 | 0 |
Total Investments | 69.89M | 73.78M | 12.1M | 0 |
Investments Growth % | - | 5.57% | -83.6% | -258.99% |
Long-Term Investments | 69.89M | 73.78M | 12.1M | 102.06M |
Accounts Receivables | 0 | 0 | 0 | 0 |
Goodwill & Intangibles | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 |
PP&E (Net) | 0 | 0 | 0 | 0 |
Other Assets | -1 | 0 | 0 | 12.28M |
Total Current Assets | 580.72K | 30.38K | 2.93K | 18.71K |
Total Non-Current Assets | 69.89M | 73.78M | 12.1M | 12.28M |
Total Assets | 70.47M▲ 0% | 73.81M▲ 4.7% | 12.1M▼ 83.6% | 12.29M▲ 0% |
Asset Growth % | - | 4.75% | -83.6% | -230.99% |
Return on Assets (ROA) | 0.24% | 3.54% | 2.47% | 3.22% |
Accounts Payable | 0 | 0 | 0 | 0 |
Total Debt | 0 | 227.7K | 2.02M | 0 |
Net Debt | -580.72K | 199.49K | 2.02M | -18.52K |
Long-Term Debt | 0 | 0 | 0 | 0 |
Short-Term Debt | 0 | 227.7K | 2.02M | 0 |
Other Liabilities | 690K | 690K | 690K | 690K |
Total Current Liabilities | 24.84K | 816.99K | 3.37M | 3.52M |
Total Non-Current Liabilities | 690K | 690K | 690K | 690K |
Total Liabilities | 714.84K | 1.51M | 4.06M | 4.21M |
Total Equity | 69.76M▲ 0% | 72.31M▲ 3.7% | 8.04M▼ 88.9% | -4.19M▲ 0% |
Equity Growth % | - | 3.66% | -88.88% | -282.03% |
Equity / Assets (Capital Ratio) | 98.99% | 97.96% | 66.44% | -34.07% |
Return on Equity (ROE) | 0.25% | 3.59% | 2.64% | 4.21% |
Book Value per Share | 7.73 | 8.01 | 1.99 | -4.03 |
Tangible BV per Share | 7.73 | 8.01 | 1.99 | -4.03 |
Common Stock | 69.89M | 73.78M | 12.1M | 12.28M |
Additional Paid-in Capital | 0 | 0 | 0 | 0 |
Retained Earnings | -134.34K | -1.48M | -4.06M | -4.19M |
Accumulated OCI | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 |
Preferred Stock | 0 | 0 | 0 | 0 |
AFJK Cash Flow Statement
Aimei Health Technology Co., Ltd (AFJK) cash flow — operating, investing & free cash flow history
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Cash from Operations | 0 | -672.29K | -565.1K | -415.7K |
Operating CF Growth % | - | - | 15.94% | 87.64% |
Net Income | 171.39K | 2.55M | 1.06M | 920.55K |
Depreciation & Amortization | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -196.23K | -3.62M | -1.9M | -1.42M |
Working Capital Changes | 24.84K | 392.5K | 270.66K | 81.25K |
Cash from Investing | -69.69M | -277.7K | 63.58M | 32.72M |
Purchase of Investments | -69.69M | 0 | 0 | 0 |
Sale/Maturity of Investments | 0 | 0 | 0 | 0 |
Net Investment Activity | -69.69M | 0 | 0 | 0 |
Acquisitions | 0 | 0 | 0 | 0 |
Other Investing | 0 | -277.7K | 63.58M | 32.72M |
Cash from Financing | 70.27M | 397.48K | -63.04M | -32.3M |
Dividends Paid | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -65.33M | -34.06M |
Stock Issued | 70.27M | 0 | 0 | 0 |
Net Stock Activity | 70.27M | 0 | -65.33M | -34.06M |
Debt Issuance (Net) | 0 | 277.7K | 1000K | 1.27M |
Other Financing | 0 | 119.78K | 539.82K | 495.54K |
Net Change in Cash | 580.72K▲ 0% | -552.51K▼ 195.1% | -25.28K▲ 95.4% | 11.17K▲ 0% |
Exchange Rate Effect | 0 | 0 | 0 | 0 |
Cash at Beginning | 0 | 580.72K | 28.21K | 2.93K |
Cash at End | 580.72K | 28.21K | 2.93K | 18.52K |
Interest Paid | 0 | 0 | 0 | 0 |
Income Taxes Paid | 0 | 0 | 0 | 0 |
Free Cash Flow | 0▲ 0% | -672.29K▲ 0% | -565.1K▲ 15.9% | -415.7K▲ 0% |
FCF Growth % | - | - | 15.94% | 43% |
AFJK Banking Ratios
Aimei Health Technology Co., Ltd (AFJK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2024 | 2025 | TTM |
|---|---|---|---|
Return on Equity (ROE) | 3.59% | 2.64% | 4.21% |
Return on Assets (ROA) | 3.54% | 2.47% | 3.22% |
Net Interest Margin | 4.9% | 15.66% | 10.55% |
Equity / Assets | 97.96% | 66.44% | -34.07% |
Book Value / Share | 8.01 | 1.99 | -4.03 |
NII Growth | 1709.88% | -47.59% | -60.75% |
Dividend Payout | - | - | 0% |
Related:AFJK Dividend History·AFJK Revenue History·AFJK Price History·AFJK P/E History·AFJK Financial Ratios·AFJK Institutional Holders
AFJK SEC Filings & Documents
Aimei Health Technology Co., Ltd (AFJK) SEC filings — annual & quarterly reports (10-K, 10-Q)
AFJK Frequently Asked Questions
Aimei Health Technology Co., Ltd (AFJK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aimei Health Technology Co., Ltd (AFJK) grew revenue by 0.0% over the past year. Growth has been modest.
Yes, Aimei Health Technology Co., Ltd (AFJK) is profitable, generating $0.9M in net income for fiscal year 2025.
Dividend & Returns
Aimei Health Technology Co., Ltd (AFJK) has a return on equity (ROE) of 2.6%. This is below average, suggesting room for improvement.
Industry Metrics
Aimei Health Technology Co., Ltd (AFJK) has a net interest margin (NIM) of 15.7%. This indicates healthy earnings from lending activities.
Aimei Health Technology Co., Ltd (AFJK) has an efficiency ratio of 0.0%. This is excellent, indicating strong cost control.